Register for the ATN Innovation Summit on June 16-17 in NYC
The Event Fitness & Wellness Owners and Operators Can't Miss.
Life Time Q1 revenue rose 11.7% and CEO Bahram Akradi calls GLP-1 weight-loss drugs "a home run" for the fitness industry.
Jeff Zwiefel, the former president and COO of Life Time and a longtime senior executive, is exiting the luxury fitness and wellness brand.
Life Time Q2 revenue rose 14% as memberships and in-center spending climbed. CEO Bahram Akradi outlines plans for clubs and AI wellness.
Life Time has opened its first club of 2025 and its second Miora clinic, where members can access weight loss meds, peptides and more.
Created by the co-founder of Restore Hyper Wellness, Humanaut is gearing up to expand its "health optimization" services across the U.S.
Luxury lifestyle and fitness operator Life Time's stock surged Wednesday on the back of strong 2023 financials and membership metrics.
ATN analyzes storylines to watch in 2024, including connected fitness, the rise of strength training and the emergence of weight loss drugs.
The anti-aging and wellness franchise offers longevity treatments as well as access to medical weight loss GLP-1s.
As consumers flock to GLP-1s, major fitness industry players like Life Time and Xponential are eager to get in on the weight-loss drug craze.
Life Time's Miora clinic has a team of doctors, physician assistants, nurses and personal trainers, and includes weight loss drugs.
Sign Up to Our Newsletter
